Further studies relate to MTHFR polymorphisms and the mechanisms of DNA repair and metabolomic studies can better clarify the relationship of the influence of these polymorphisms on the risk of BC, glioma and CG. This evidence concerns the gene MTHFR and central nervous system cancer.